Skip to main content
Astellas Pharma Inc. (TYO:4503)
Japan flag Japan · Delayed Price · Currency is JPY
2,306.00
-79.50 (-3.33%)
Apr 28, 2026, 3:30 PM JST

Astellas Pharma Revenue

In the fiscal year ending March 31, 2026, Astellas Pharma had annual revenue of 2.14T JPY with 11.87% growth. Astellas Pharma had revenue of 554.57B in the quarter ending March 31, 2026, with 20.74% growth.

Revenue
2,139.25B
Revenue Growth
+11.87%
P/S Ratio
1.93
Revenue / Employee
156.80M
Employees
13,643
Market Cap
4,131.18B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 20262,139.25B226.92B11.87%
Mar 31, 20251,912.32B308.65B19.25%
Mar 31, 20241,603.67B85.05B5.60%
Mar 31, 20231,518.62B222.46B17.16%
Mar 31, 20221,296.16B46.64B3.73%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Daiichi Sankyo Company 2,052.15B
Otsuka Holdings 2,468.89B
Chugai Pharmaceutical 1,291.23B
Kyowa Kirin 496.83B
Ono Pharmaceutical 509.35B
Santen Pharmaceutical 287.99B
JCR Pharmaceuticals 37.55B
Perseus Proteomics 140.41M
Revenue Rankings

Astellas Pharma News

More News